Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Roman Michael F, holds the title of Director at ABBOTT LABORATORIES.
On 2025-03-31, the insider transacted 265 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Roman Michael F (Director) was granted $0 of $ABT
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.